Marcus M. Reidenberg

Author

Cornell University

Also Known As

Kent Johnson, M M Reidenberg, MARCUS M. REIDENBERG, Marcus M Reidenberg, Marcus M. Reidenberg

195

Publications

6.7K

Citations

H-Index

182

Concepts

All Affiliations

Cornell University NewYork–Presbyterian Hospital Temple University Memorial Sloan Kettering Cancer Center

About

Marcus M. Reidenberg is an author at Cornell University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	50	3.8K
2	Health Sciences	10	10	520
3	Public Health	4	4	236
4	Natural Sciences	3	3	90
5	Education	1	1	24

Marcus M. Reidenberg

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Central nervous system excitatory effects of meperidine in cancer patients Robert F. Kaiko, Kathleen M. Foley, Patricia Y. Grabinski, Annals of Neurology	1983	410
Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus Syndrome Raymond L. Woosley, Dennis E. Drayer, Marcus M. Reidenberg, New England Journal of Medicine ImmunologyPathologyPharmacotherapyImmunotherapyAcetylator Phenotype	1978	387
Protein Binding of Diphenylhydantoin and Desmethylimipramine in Plasma from Patients with Poor Renal Function Marcus M. Reidenberg, Ingegerd Odar‐Cederlöf, Christer von Bahr, New England Journal of Medicine Dialysis TherapyPharmacotherapyPoor Renal FunctionDmi BindingRenal Function	1971	296
Adverse Nondrug Reactions Marcus M. Reidenberg, David Löwenthal, Raymond Sacks New England Journal of Medicine PharmacotherapyDrug AllergyHealthy University StudentsAdverse Drug ReactionHospital Medicine	1968	248
Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial Catherine Van Poznak, Andrew D. Seidman, Marcus M. Reidenberg, Breast Cancer Research and Treatment Oral GossypolBreast OncologyOncologyPharmacologyBreast Cancer	2001	218
Polymorphic acetylation of procainamide in man Marcus M. Reidenberg, Dennis E. Drayer, Micha Levy, Clinical Pharmacology & Therapeutics	1975	181
Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function Kenneth M. Kessler, David Löwenthal, Howard Warner, New England Journal of Medicine Heart FailureCardiovascular PharmacologyPharmacotherapyPoor Renal FunctionDiastolic Function	1974	157
Clinical consequences of polymorphic acetylation of basic drugs Dennis E. Drayer, Marcus M. Reidenberg Clinical Pharmacology & Therapeutics Pharmaceutical ScienceRelative RiskPharmacotherapySpontaneous SleExperimental Pharmacology	1977	153
INFLUENCE OF DISEASE ON BINDING OF DRUGS TO PLASMA PROTEINS* Marcus M. Reidenberg, Melton B. Affrime Annals of the New York Academy of Sciences Drug TargetMedicinePharmacotherapyClinical ChemistryPharmacology	1973	148
Phenytoin in the treatment of diabetic symmetrical polyneuropathy Christopher D. Saudek, S.W. Werns, Marcus M. Reidenberg Clinical Pharmacology & Therapeutics	1977	143

Page 1